Clinical Trial Update: Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of capsaicin patch (Qutenza) for cancer-related neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• QUTENZA (Capsaicin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED